Fereshteh Saddadi
1* , Mohammad Hassan Fallahkohan
2 1 Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
2 Shahid Beheshti University of Medical Campus, Tehran, Iran
Abstract
Choice of maintenance immunosuppressive therapy after renal transplantation is important for graft survival. However, complication may also occur. Venous thromboembolic event with the mTOR inhibitor (mTORi) everolimus is a rare but life-threatening complication. Here we describe a renal transplant recipient who developed pulmonary thromboembolism.
Implication for health policy/practice/research/medical education:
Paying attention to the major side effects of immunosuppressive drugs can be effective in selecting and preventing bad events.
Please cite this paper as: Saddadi F, Fallahkohan M. Everolimus induced pulmonary thromboembolism after kidney transplantation; a case report. J Nephropathol. 2022;11(1):e11. DOI: 10.34172/jnp.2022.11.